Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 828-838
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.828
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.828
Figure 2 Recurrence-free survival and overall survival were stratified by low/high levels of haemoglobin, albumin, lymphocyte, and platelet in both female and male pancreatic cancer patients.
A: Recurrence-free survivals were stratified by low/high levels of HALP (hemoglobin, albumin, lymphocyte, and platelet) in female patients. B: Overall survivals were stratified by low/high levels of HALP in female patients. C: Recurrence-free survivals were stratified by low/high levels of HALP in male patients. D: Overall survivals were stratified by low/high levels of HALP in male patients. HALP: Hemoglobin, albumin, lymphocyte, and platelet.
- Citation: Xu SS, Li S, Xu HX, Li H, Wu CT, Wang WQ, Gao HL, Jiang W, Zhang WH, Li TJ, Ni QX, Liu L, Yu XJ. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World J Gastroenterol 2020; 26(8): 828-838
- URL: https://www.wjgnet.com/1007-9327/full/v26/i8/828.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i8.828